Caroline Fronczak Alvebratt is a Researcher at the Department of Pharmacy, specializing in Molecular Galenic Pharmacy at Uppsala University. Her work focuses on developing and evaluating advanced drug delivery systems, particularly for poorly water-soluble pharmaceutical compounds. She is based at the Biomedical Center BMC in Uppsala, Sweden, with postal address Box 580, 751 23 UPPSALA. Research Interests Dr. Alvebratt's research centers on pharmaceutical formulation science with particular expertise in: Development and evaluation of complex drug delivery systems Supersaturating and solubilizing formulations for poorly water-soluble drugs Mesoporous magnesium carbonate as a drug carrier material Advanced in vitro testing methodologies for drug dissolution and release Chemical stability of lipid-based drug formulations Interlaboratory validation of small-scale pharmaceutical testing methods Her work bridges pharmaceutical materials science with practical drug delivery applications, focusing on improving bioavailability of challenging drug compounds through innovative formulation approaches. Publication Trends Dr. Alvebratt's publication record demonstrates consistent focus on advanced drug delivery methodologies since 2016. Her research has evolved from basic dissolution testing methods to increasingly sophisticated multi-parameter evaluation systems that incorporate digestion and permeation components. A significant portion of her work examines mesoporous magnesium carbonate as a novel drug carrier material, exploring its interactions with both lipid-based and polymer-based formulations. Recent publications indicate growing interest in combining multiple formulation approaches to maximize drug bioavailability, suggesting a trend toward more complex, integrated drug delivery solutions. Collaborations and Research Context Dr. Alvebratt appears to work within a collaborative research environment at Uppsala University, frequently co-authoring with researchers including Christel Bergström, Maria Strömme, and several international collaborators. Her work often involves interdisciplinary approaches combining pharmaceutical sciences, materials science, and analytical chemistry to address challenges in drug delivery. While specific grant information isn't provided in the available text, her consistent publication record suggests ongoing research support for her work in advanced drug delivery systems.
